Edwards Lifesciences Stock Forecast

Stock Price Forecast

According to 28 analysts polled by S&P Global, Edwards Lifesciences stock has a consensus rating of "Buy" and an average price target of $100.96. The average 1-year stock price forecast is 11.92% higher than the current stock price, while the lowest is $84 (-6.88%) and the highest is $110 (+21.94%).

Price Target: $100.96 (+11.92%)

Analyst Consensus: Buy

Price Target

Chart

Target	Low	Average	Median	High
Price	$84	$100.96	$101.5	$110
Change	-6.88%	+11.92%	+12.52%	+21.94%

Analyst Ratings

The average analyst rating for Edwards Lifesciences stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Chart

Rating	Mar '26	Apr '26	May '26	Jun '26	Jul '26	Aug '26
Strong Buy	16	17	17	17	17	17
Buy	5	5	4	4	4	4
Hold	10	8	8	8	7	7
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	31	30	29	29	28	28

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Brandon Vazquez William Blair	William Blair	Buy Maintains n/a	Buy	Maintains	n/a	n/a	Aug 18, 2026
Joanne Wuensch Citi	Citi	Buy Reiterates $110	Buy	Reiterates	$110	+21.94%	Aug 13, 2026
William Plovanic Canaccord Genuity	Canaccord Genuity	Hold Maintains $85	Hold	Maintains	$85	-5.78%	Aug 4, 2026
Robbie Marcus J.P. Morgan	J.P. Morgan	Buy Maintains $105	Buy	Maintains	$105	+16.40%	Jul 29, 2026
Patrick Wood UBS	UBS	Buy Upgrades $90 → $110	Buy	Upgrades	$90 → $110	+21.94%	Jul 28, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

6.76B

from 6.07B

11.40%

from 6.07B

Revenue Next Year

7.43B

from 6.76B

9.91%

from 6.76B

EPS This Year

3.00

from 2.56

17.17%

from 2.56

EPS Next Year

3.38

from 3.00

12.60%

from 3.00

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	5.23B	4.46B	5.01B	5.44B	6.07B	6.76B
Revenue Growth	19.29%	-14.69%	12.23%	8.57%	11.55%	11.40%
Gross Profit	3.98B	3.74B	4.03B	4.32B	4.73B	5.28B
Gross Margin	76.13%	83.82%	80.47%	79.46%	78.01%	78.14%
Operating Income	1.59B	1.54B	1.49B	1.48B	1.64B	1.97B
Net Income	1.50B	1.52B	1.40B	4.17B	1.07B	1.44B
EPS	-	-	-	-	2.56	3.00
EPS Growth	-	-	-	-	5.35%	17.17%
Forward PE	52.98	30.35	28.41	31.19	30.93	30.08
Free Cash Flow	1.01B	776.73M	566.93M	1.34B	1.17B	848.93M
No. Analysts	-	-	-	-	-	28

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Chart

Revenue	2026	2027	2028
High	6.8B
Avg	6.8B
Low	6.7B

Revenue Growth

Chart

Revenue Growth	2026	2027	2028
High	12.7%
Avg	11.4%
Low	9.8%

EPS Forecast

Chart

EPS	2026	2027	2028
High	3.05
Avg	3.00
Low	2.96

EPS Growth

Chart

EPS Growth	2026	2027	2028
High	19.1%
Avg	17.2%
Low	15.6%